Loading
Genetics and Neurodevelopmental Disorders / Williams Syndrome Research · Journal article
Frontiers in Cell and Developmental Biology · September 4, 2026
Raises a question worth testing. It does not answer one.
This is a zebrafish genetic model study demonstrating that tcf4 haploinsufficiency causes craniofacial skeletal abnormalities and impaired gastrointestinal motility phenotypes consistent with human Pitt-Hopkins syndrome. Rescue experiments confirm TCF4 specificity and suggest the pathway involves reduced enteric neural progenitors and neurons, but the work remains mechanistic and exploratory in a non-mammalian organism.
Zebrafish genetic model with functional characterization and rescue experiments. Zebrafish (Danio rerio) tcf4 mutant and wild-type larvae and embryos. Intervention: Heterozygous tcf4 mutation via CRISPR/Cas9; human TCF4 mRNA reintroduction; TCF4 mRNA overexpression. Compared with: Wild-type or heterozygous mutant controls; baseline phenotype versus rescue state.
Heterozygous tcf4 mutants exhibit craniofacial skeletal abnormalities and impaired gastrointestinal motility Functional analysis revealed significant reduction of spontaneous peristaltic contractions and delayed swallow-induced gut transit Defects associated with reduced number of Phox2b-positive enteric progenitors and HuC-positive enteric neurons
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
This foundational work identifies TCF4-dependent neural crest pathways relevant to PTHS craniofacial and enteric phenotypes and provides a platform for testing therapeutic strategies, but conclusions require validation in mammalian models and human tissue before informing clinical practice.
A mechanistic study using a novel animal model to elucidate developmental pathways in a rare disorder; generates testable hypotheses about TCF4 function but does not provide clinical evidence or human validation.
As stated by the source record.
This foundational work identifies TCF4-dependent neural crest pathways relevant to PTHS craniofacial and enteric phenotypes and provides a platform for testing therapeutic strategies, but conclusions require validation in mammalian models and human tissue before informing clinical practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no reported figures. That is a gap in the analysis, not a judgement about the study.
Background Pitt-Hopkins Syndrome (PTHS) is a rare neurodevelopmental disorder caused by haploinsufficiency of the TCF4 gene. It is characterized by intellectual disability, distinctive facial features, breathing abnormalities, and gastrointestinal dysfunction. While the role of TCF4 in central nervous system development has been extensively investigated, the developmental basis underlying craniofacial and enteric alterations remains poorly understood. Methods We generated a zebrafish tcf4 mutant line using CRISPR/Cas9 genome editing to unveil the role of Tcf4 in neural crest-derived lineages that contribute to craniofacial and Enteric Nervous System development. The model was characterized by multiple integrated approaches to evaluate the morphological, cellular and functional alterations associated with tcf4 haploinsufficiency. As a proof-of-concept that the observed phenotypes resulted from Tcf4 loss of function, we reinstated human TCF4 expression in mutant larvae and assessed the rescue of the pathological phenotypes previously described. Results Heterozygous mutants exhibit key features of PTHS, including craniofacial skeletal abnormalities and impaired gastrointestinal motility. Functional analysis revealed a significant reduction of spontaneous peristaltic contractions and a delayed swallow-induced gut transit, consistently with human patients and PTHS mouse model. To further elucidate these developmental alterations, we showed that these defects are associated with a reduced number of Phox2b-positive enteric progenitors and HuC-positive enteric neurons, though early vagal neural crest migration appears unaffected. Reintroducing human TCF4 mRNA in tcf4 heterozygous mutant embryos rescues both craniofacial and gastrointestinal phenotypes, confirming the specificity of the observed phenotypes. Furthermore, we showed that the human TCF4 mRNA overexpression can alter craniofacial development in zebrafish embryos suggesting that TCF4 reinstatement dosage should be evaluated in gene therapy approaches to avoid a gain of function phenotype. Conclusion Together, our results shed light on TCF4 as a key regulator of neural crest-derived lineages and provide a new perspective on two major clinical features of PTHS. The tcf4 mutant line represents a novel in vivo platform for investigating PTHS pathogenesis at cellular and molecular level and testing novel therapeutic strategies
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.